Short Squeeze Scan — 2026-10-18

Algolearn.AI October 18, 2026 4 min read 4 views


Squeeze 2026-10-18 · 1 top setup · 6 watchlist · 23 no signal

Automated daily scan of high-short-interest US stocks, scored against a 7-point short-squeeze checklist (the same warning signs that preceded the April 2026 CAR squeeze). Each top setup includes a defined-risk options idea built from live chain data. Not investment advice.

Top setups

HTZ (5/7)

Hertz carries the highest short interest on today's scan at 68.07% of float with 8.51 DTC, and borrow costs have surged to 26.48% APR (from 14.77%) with zero IBKR shares available — a classic borrow-tightening setup. Q3 2026 earnings on November 5 provide a hard catalyst: the prior Q2 beat triggered a +50% two-day short squeeze in August, and consensus now expects EPS +118.3% YoY. The Nov 6 options chain confirms directional positioning — call 25d IV of 164.84% vs put 25d IV of 127.65% (-22.56% skew), meaning the market is explicitly pricing asymmetric upside squeeze risk ahead of earnings. Price momentum is absent (stock at $1.73, faded from $2.24 peak), which is the primary risk; if buyers do not emerge pre-earnings, the setup could stall despite perfect squeeze conditions.

  • [PASS] Short interest > 40% of float: 68.07% of float per highshortinterest.com; 115.9M shares short as of Sep 15 2026 settlement (altindex.com); highest SI in today's 30-stock scan
  • [PASS] Days to cover > 5: 8.51 DTC per altindex.com (115.9M shares short ÷ ~13.6M avg daily volume); above the 5-day threshold
  • [FAIL] Tiny free float with institutions locked up: Float 170.6M of 356.45M outstanding; ~52.1% of shares are insider/institution-locked, below the 75% threshold required
  • [PASS] Rising borrow costs: Borrow fee surged to 26.48% APR from 14.77%; zero shares available to short on Interactive Brokers as of Oct 2026 (fintel.io/altindex.com)
  • [PASS] Near-term catalyst (earnings, FDA, tariff, etc.): Q3 2026 earnings scheduled November 5 2026 (18 days away); consensus expects EPS +118.3% YoY; prior Q2 2026 beat triggered a +50% two-day short squeeze in August 2026
  • [PASS] Heavy call buying / call skew > put skew: Nov 6 chain (theta data): call 25d IV 164.84% vs put 25d IV 127.65% (-22.56% negative skew — calls priced 37.19pp above equidistant puts); ATM IV 140.78%; implied move 25.5% through the Nov 5 earnings date
  • [FAIL] Price momentum turning up despite heavy short interest: Closed $1.73 Oct 16, faded from $2.24 high Oct 7 (53.8M vol); 30-day trend from $2.19 open is negative; Oct 6–7 volume-surge gains have not held
Strategybull call spread
Expiry2026-11-06
Legslong 1x $2.00 call, short 1x $3.50 call
Cost$0.075 debit per spread
Max risk / reward$7.50 per spread / $142.50 per spread · breakeven $2.075

Watchlist

TickerScoreSummary
GRPN3/7Groupon has the second-highest SI on the scan at 56.5% of float with 9.5 DTC, and Q3 earnings on Nov 5 bring a hard catalyst alongside an improving EBITDA trajectory ($75–80M guidance lift) and AI-native restructuring story. However borrow at 1.66% is too cheap to signal short distress, no liquid options chain exists to confirm call positioning, and the stock has declined 17% from its Sep 21 peak to $16.57 — momentum is negative heading into the print.
XPOF3/7Xponential Fitness has 45.48% SI of float and 17.01 DTC — the highest DTC on the watchlist — with Q3 earnings on Nov 5 as the hard catalyst. Guidance was cut and $40M in legal settlement costs are pressuring the business, but shorts are short a stock that has already declined significantly from highs; a better-than-feared Q3 print could trigger forced covering over 17 DTC. No liquid options chain and unconfirmed borrow rate preclude a higher score.
UPST3/7Upstart has 33.1% SI of float (below the 40% flag) with 6.22 DTC and Q3 earnings in 16 days (Nov 3), following a Q2 quarter where the company returned to GAAP profitability on +50% YoY originations. The Oct 14–15 price recovery from $22.21 to $24.75 on above-average volume shows momentum turning up heading into earnings. Options skew is normal (puts modestly > calls), and high institutional ownership at 65.61% limits float-squeeze dynamics.
NEGG3/7Newegg has an extraordinarily tiny free float of 1.58M shares (92.5% insider lockup) with borrow at 33.97% APR; Ortex previously reported SI as high as 174% of float before Sep 2026 insider purchases locked additional shares. The structural squeeze fuel — extreme float constraint, elevated borrow, long DTC — is the strongest of the watchlist, but the 30-day price decline of -28% and the absence of a near-term catalyst or liquid options market mean there is nothing actionable today.
FLWS3/71-800-Flowers has the highest DTC on today's scan at 30.92 days, and earnings arrive in 11 days (Oct 29) entering Q4 peak gifting season. The Nov 20 options chain shows a dramatic -26.57% negative skew (call 25d IV 187.26% vs put 25d IV 137.5%), and Oct 16 saw anomalous volume of 2.95M shares — 8.4x the 30-day average. SI is 36.59% per HS.com (below the 40% flag threshold), borrow rate is unconfirmed, and the 30-day price trend is still negative, keeping this on the watchlist; upgrade to top setup if borrow rate confirms as elevated or price holds above $2.75 into earnings.
BETR3/7Better Home & Finance has 42.03% SI of float and 5.8 DTC, and the Nov 20 options show ATM IV of 143% with a -10.16% call skew alongside a dramatic Oct 15 intraday spike (+41% on 5.6x volume) that may represent a failed squeeze attempt or the early stage of a building setup. Borrow is cheap (1.32–3.59% APR) and no specific catalyst has been identified, limiting conviction; the spike faded to $9.95 by Oct 16 and the 30-day trend remains negative.

No signal

LCID, KPTI, PLCE, ONDS, SERV, SOUN, WGS, AI, TE, FLNC, CRML, PCT, RXRX, METC, QUBT, XRX, RUN, CCCC, SPRY, EOSE, BBAI, SLS, FCEL


Generated 2026-10-18 15:00 UTC by the AlgoLearn squeeze scanner. Defined-risk options ideas for informational purposes only — not investment advice.

https://pagerankcafe.com/pressRelease/blog/squeeze-scan-2026-10-18

Share this article

𝕏 Post Facebook LinkedIn Email

Related Articles